US 11130726
Therapeutic compounds and methods of use thereof
granted A61PA61P17/04A61P25/00
Quick answer
US patent 11130726 (Therapeutic compounds and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P17/04, A61P25/00, A61P29/00